Invenomic Capital Management’s RE/MAX Holdings RMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Sell
195,990
-10,983
-5% -$76K 0.05% 141
2025
Q4
$1.57M Sell
206,973
-4,704
-2% -$38.2K 0.07% 137
2025
Q3
$2M Sell
211,677
-11,314
-5% -$99.9K 0.1% 133
2025
Q2
$1.82M Buy
222,991
+47,588
+27% +$369K 0.1% 139
2025
Q1
$1.47M Buy
+175,403
New +$1.67M 0.07% 158

Other funds holding RMAX

Invenomic Capital Management's RMAX Position: Q1 2026 in Review

Invenomic Capital Management reduced its RE/MAX Holdings (RMAX) stake by 5.3% in Q1 2026, selling an estimated $76K and leaving 195,990 shares worth $1.13M. The position accounts for 0.05% of the portfolio, ranked #141.

Invenomic Capital Management first reported a position in RMAX in Q1 2025 and has held it in 5 quarters since. The position peaked at $2M in Q3 2025. 125 funds tracked by Wall St. Rank hold RMAX as of Q1 2026.

  • Invenomic Capital Management held 195,990 shares of RE/MAX Holdings worth $1.13M as of Q1 2026.
  • Invenomic Capital Management sold 10,983 RE/MAX Holdings shares in Q1 2026, an estimated $76K.
  • RE/MAX Holdings made up 0.05% of Invenomic Capital Management's portfolio in Q1 2026, its #141 holding.
  • Invenomic Capital Management first reported a position in RE/MAX Holdings in Q1 2025 and has held it in 5 quarters since.
  • Invenomic Capital Management's RE/MAX Holdings position peaked at $2M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held RE/MAX Holdings as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.